These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21428710)

  • 1. The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis.
    Aktunc E; Kayhan B; Arasli M; Gun BD; Barut F
    Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):667-75. PubMed ID: 21428710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
    Liu W; Li WM; Gao C; Sun NL
    J Autoimmun; 2005 Dec; 25(4):258-63. PubMed ID: 16242301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interferon-beta and atorvastatin on Th1/Th2 cytokines in multiple sclerosis.
    Sellner J; Greeve I; Findling O; Kamm CP; Minten C; Engelhardt B; Grandgirard D; Leib SL; Mattle HP
    Neurochem Int; 2008 Jul; 53(1-2):17-21. PubMed ID: 18524417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study.
    Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F
    Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of atorvastatin in experimental autoimmune uveitis.
    Thomas PB; Albini T; Giri RK; See RF; Evans M; Rao NA
    Br J Ophthalmol; 2005 Mar; 89(3):275-9. PubMed ID: 15722302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis.
    Bai A; Ma AG; Yong M; Weiss CR; Ma Y; Guan Q; Bernstein CN; Peng Z
    Biochem Pharmacol; 2010 Dec; 80(11):1708-17. PubMed ID: 20797389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells.
    Li XL; Dou YC; Liu Y; Shi CW; Cao LL; Zhang XQ; Zhu J; Duan RS
    Cell Immunol; 2011; 271(2):455-61. PubMed ID: 21889126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines.
    Finnegan A; Mikecz K; Tao P; Glant TT
    J Immunol; 1999 Nov; 163(10):5383-90. PubMed ID: 10553063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect.
    Gotsman I; Shlomai A; Alper R; Rabbani E; Engelhardt D; Ilan Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):926-32. PubMed ID: 11356912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fumigaclavine C, an fungal metabolite, improves experimental colitis in mice via downregulating Th1 cytokine production and matrix metalloproteinase activity.
    Wu XF; Fei MJ; Shu RG; Tan RX; Xu Q
    Int Immunopharmacol; 2005 Sep; 5(10):1543-53. PubMed ID: 16023606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development.
    Hakamada-Taguchi R; Uehara Y; Kuribayashi K; Numabe A; Saito K; Negoro H; Fujita T; Toyo-oka T; Kato T
    Circ Res; 2003 Nov; 93(10):948-56. PubMed ID: 14563711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.
    Obermeier F; Dunger N; Deml L; Herfarth H; Schölmerich J; Falk W
    Eur J Immunol; 2002 Jul; 32(7):2084-92. PubMed ID: 12115630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine expression and the role of Thl7 cells in mice colitis.
    He Y; Lin LJ; Zheng CQ; Jin Y; Lin Y
    Hepatogastroenterology; 2012 Sep; 59(118):1809-13. PubMed ID: 23115792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans retinoic acid ameliorates trinitrobenzene sulfonic acid-induced colitis by shifting Th1 to Th2 profile.
    Bai A; Lu N; Zeng H; Li Z; Zhou X; Chen J; Liu P; Peng Z; Guo Y
    J Interferon Cytokine Res; 2010 Jun; 30(6):399-406. PubMed ID: 20187766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
    Phoon RK; Kitching AR; Jones LK; Holdsworth SR
    Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.